Skip to main content
NTLA
NASDAQ Life Sciences

Intellia Posts $127.5M Q3 Loss as Cash Burn Accelerates

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$12.3
Mkt Cap
$1.725B
52W Low
$7.95
52W High
$18.48
52W Position info
55% above low
Off High info
33% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

NTLA sits 55% above its 52-week low of $7.95.

Summary

Intellia reported a third-quarter net loss of $127.5 million, up from the $106.6 million loss it posted in Q2 2026, with a loss per share of 91c and revenue of $7.16 million. Research and development expenses came in at $83.3 million. The widening deficit matters for a clinical-stage gene-editing company whose story rests on funding the lonvo-z launch without heavy dilution. It follows the $400 million OrbiMed term loan closed in September, of which only $75 million was drawn upfront, and the FDA's Priority Review acceptance of the lonvo-z BLA. Intellia expects the lonvo-z launch in Q1 2027, and the PDUFA date for lonvo-z is March 10, 2027.

At the time of this announcement, NTLA was trading at $12.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $7.95 to $18.48. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

NTLA - Latest Insights

NTLA
Nov 12, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.60
Real-time Price: $9.43 info
Change: -$1.17 (-11%) info
Market Cap: $1.336B info
NTLA
Nov 12, 2026, 10:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.72
Real-time Price: $9.43 info
Change: -$1.29 (-12%) info
Market Cap: $1.336B info
NTLA
Sep 08, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.74
Real-time Price: $9.43 info
Change: -$3.31 (-26%) info
Market Cap: $1.336B info
NTLA
Sep 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $13.69
Real-time Price: $9.43 info
Change: -$4.26 (-31%) info
Market Cap: $1.336B info
NTLA
Sep 04, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.75
Real-time Price: $9.43 info
Change: -$3.32 (-26%) info
Market Cap: $1.336B info